InterventionsHumansPreprint4.6 yearsCohort study

GLP-1 Receptor Agonist Initiation Is Associated With Excess Skeletal Muscle Loss in Adults With Diabetes: A Prospective Population-Based MRI Study

Figure 1. Cohort flow to the analyzed sample. — Figure 1. Cohort flow to the analyzed sample.Cohort flow to the analyzed sample.Stambollxhiu et al. · CC BY-NC-ND

medRxiv

The paper

Stambollxhiu E, Luebberstedt J, Kumpf M et al.

medRxiv · 17 Sep 2026 · CC BY-NC-ND · Preprint, not peer-reviewed

doi.org/10.64898/2026.09.15.26363157

SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Neurology Genetics · 4 Oct 2026